Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia
Atsushi Yamada(Kyoto University), Ajay Goel(City of Hope), Manabu Muto(Kyoto University), Naoshi Nishida(Kindai University), Hiroshi Ida(Kyoto Prefectural Police), Hajime Honjo(Otsu Red Cross Hospital), Toshihiro Kusaka(Kyoto Katsura Hospital), Makato Yagi(Yamagata University), Takahiro Horimatsu(Kyoto University), Yoshiyuki Ueno(Yamagata University), Yu Sasaki(Yamagata University), Yusuke Amanuma(Kyoto University), Tadayuki Kou(Kitano Hospital), Norio Yukawa(Yokohama City University), C. Richard Boland(Baylor University Medical Center), Osamu Kikuchi(Kyoto University), Atsushi Nakajima(Yokohama City University Hospital), Yoshinaga Okugawa(Mie University), Tsutomu Chiba(Kyoto University), Takuma Higurashi(Yokohama City University Hospital)
Cited by 157
Related Papers
Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers
|Gastroenterology|2015|814
Molecular Classification and Correlates in Colorectal Cancer
|Journal of Molecular Diagnostics|2007|460
Correlation of CD133, OCT4, and SOX2 in Rectal Cancer and Their Association with Distant Recurrence After Chemoradiotherapy
|Annals of Surgical Oncology|2009|324
Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer
|Annals of Surgery|2019|298
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|271